Literature DB >> 32335751

ASO Author Reflections: No Profiling in Male Breast Cancer: Where We are and Where We Should Be.

Austin D Williams1, Lucy M De La Cruz2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32335751     DOI: 10.1245/s10434-020-08504-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

2.  A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.

Authors:  Abeer M Shaaban; Graham R Ball; Rebecca A Brannan; Gabor Cserni; Anna Di Benedetto; Jo Dent; Laura Fulford; Helen Honarpisheh; Lee Jordan; J Louise Jones; Rani Kanthan; Loaie Maraqa; Maria Litwiniuk; Marcella Mottolese; Steven Pollock; Elena Provenzano; Philip R Quinlan; Georgina Reall; Sami Shousha; Mark Stephens; Eldo T Verghese; Rosemary A Walker; Andrew M Hanby; Valerie Speirs
Journal:  Breast Cancer Res Treat       Date:  2011-11-18       Impact factor: 4.872

3.  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Matthew P Goetz; John A Olson; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter M Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; Jeffrey L Berenberg; Jeffrey Abrams; George W Sledge
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

4.  Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.

Authors:  Austin D Williams; Christopher M McGreevy; Julia C Tchou; Lucy M De La Cruz
Journal:  Ann Surg Oncol       Date:  2020-05-29       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.